InflaRx N.V. Forecast, price target & analysts
InflaRx N.V. Target price 2025 - Analyst rating & recommendation
InflaRx N.V. Classifications & Recommendation:
InflaRx N.V. Price Target
| Target Price | $3.06 |
| Price | $0.81 |
| Potential |
278.81%
register free of charge
|
| Number of Estimates | 9 |
|
9 Analysts have issued a price target InflaRx N.V. 2026 .
The average InflaRx N.V. target price is $3.06.
This is
278.81%
register free of charge
$10.50
1,199.83%
register free of charge
$2.02
150.06%
register free of charge
|
|
| A rating was issued by 14 analysts: 12 Analysts recommend InflaRx N.V. to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the InflaRx N.V. stock has an average upside potential 2026 of
278.81%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.19 | 0.11 |
| 171.43% | 39.84% | |
| EBITDA Margin | -32,394.74% | -1,255.23% |
| 56.33% | 96.13% | |
| Net Margin | -28,415.79% | -47,018.93% |
| 60.23% | 65.47% |
9 Analysts have issued a sales forecast InflaRx N.V. 2025 . The average InflaRx N.V. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an InflaRx N.V. EBITDA forecast 2025. The average InflaRx N.V. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-61.6m | 18.52% |
|---|---|---|
| 2025 |
$-1.4m
97.67%
Unlock
|
|
EBITDA Margin
| 2024 | -32,394.74% | 56.33% |
|---|---|---|
| 2025 |
-1,255.23%
96.13%
Unlock
|
|
9 InflaRx N.V. Analysts have issued a net profit forecast 2025. The average InflaRx N.V. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.91 | -0.85 |
| 0.00% | 6.59% | |
| P/E | negative | |
| EV/Sales | negative |
9 Analysts have issued a InflaRx N.V. forecast for earnings per share. The average InflaRx N.V. EPS is
This results in the following potential growth metrics and future valuations:
Current InflaRx N.V. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 29 2025 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 08 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Mar 26 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 07 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jan 16 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 29 2025 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
Apr 29 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Mar 26 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 21 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 07 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jan 16 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
